NeOnc Technologies Holdings is trading 15.01% down now at $4.70 after a sharp multi-session rally.

  • The stock rose 31.46% on August 14, 16.35% on August 17, and 12.63% on August 18.
  • The rally followed positive Phase 2a NEO100 glioma results.
  • Available coverage identifies the August 19 decline as a pullback, with no new negative company-specific announcement reported for August 19.